Supernus Pharmaceuticals ... (SUPN)

NASDAQ: SUPN · Real-Time Price · USD

32.49

0.24 (0.74%)

At close: Apr 29, 2025, 3:59 PM

32.49

0.00%

After-hours: Apr 29, 2025, 04:05 PM EDT

Supernus Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	661.82M	607.52M	667.24M	579.77M	520.4M	392.75M	408.9M	302.24M	215M
Cost of Revenue	77.91M	83.78M	87.22M	75.06M	52.46M	16.66M	15.36M	15.21M	11.99M
Gross Profit	583.91M	523.74M	580.02M	504.71M	467.94M	376.1M	393.54M	287.02M	203.02M
Operating Income	81.67M	-5.27M	67.3M	86.03M	173.7M	148.57M	144.44M	99.54M	54.22M
Interest Income	16.2M	10.45M	21.69M	10.57M	18.7M	21.62M	13.84M	2.86M	1.48M
Pretax Income	97.87M	2.77M	60.74M	73.17M	168.65M	147.49M	140.18M	100.62M	50.37M
Net Income	73.86M	1.32M	60.71M	53.42M	126.95M	113.06M	110.99M	57.28M	91.22M
Selling & General & Admin	321.58M	336.36M	377.22M	304.76M	200.68M	158.43M	159.89M	137.91M	106.01M
Research & Development	108.8M	91.59M	74.55M	90.47M	75.96M	69.1M	89.21M	49.58M	42.79M
Other Expenses	71.87M	101.06M	82.63M	29.99M	15.7M	n/a	n/a	n/a	-15K
Operating Expenses	502.25M	529.01M	534.4M	425.21M	292.34M	227.52M	249.1M	187.48M	148.8M
Interest Expense	n/a	2.42M	7.07M	23.42M	23.75M	22.71M	18.11M	1.57M	5.09M
Selling & Marketing Expenses	227.29M	99.7M	267.79M	199.71M	134.75M	40.8M	43.3M	33.8M	21.9M
Cost & Expenses	580.15M	612.79M	621.62M	500.28M	344.8M	244.18M	264.45M	202.7M	160.79M
Income Tax Expense	24M	1.45M	32K	19.75M	41.7M	34.43M	29.18M	43.33M	-40.85M
Shares Outstanding (Basic)	55.1M	54.54M	53.67M	53.1M	52.62M	52.41M	51.99M	50.76M	49.47M
Shares Outstanding (Diluted)	55.96M	55.51M	61.68M	54.36M	53.69M	53.82M	54.1M	53.3M	51.71M
EPS (Basic)	1.34	0.02	1.13	1.01	2.41	2.16	2.13	1.13	1.84
EPS (Diluted)	1.32	0.02	1.04	0.98	2.36	2.10	2.05	1.08	1.76
EBITDA	178.28M	90.04M	153.44M	129.19M	212.4M	180.42M	151.51M	107.67M	56.62M
EBIT	97.87M	5.18M	67.81M	96.6M	192.4M	170.19M	144.44M	99.54M	54.22M
Depreciation & Amortization	80.41M	84.86M	85.63M	32.59M	20M	10.22M	7.06M	8.13M	2.4M